# DESIGN THERAPEUTICS INC (DSGN)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/DSGN/

- Reporting holders: 3
- Reported value: $28.4K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $26.8K | 2,135 | 0.0% | 5 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $1.1K | 86 | 0.0% | 2 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $478 | 38 | 0.0% | 9 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 3 | $28.4K |
| Q2 2026 | 139 | $665.8M |
| Q1 2026 | 125 | $406.8M |
| Q4 2025 | 118 | $364.4M |
| Q3 2025 | 96 | $271.4M |
| Q2 2025 | 93 | $116.4M |
| Q1 2025 | 96 | $133.0M |
| Q4 2024 | 94 | $206.6M |
| Q3 2024 | 99 | $172.8M |
| Q2 2024 | 92 | $124.5M |
| Q1 2024 | 90 | $127.9M |
| Q4 2023 | 87 | $86.3M |